1. Home
  2. Analysis
  3. Morphine-sulfate
  4. Hepatocellular-damage

Morphine sulfate and Hepatocellular damage - a phase IV clinical study of FDA data

Summary:

Hepatocellular damage is reported as a side effect among people who take Morphine sulfate (morphine sulfate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Bactrim, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Hepatocellular damage when taking Morphine sulfate. It is created by eHealthMe based on reports of 86,091 people who have side effects when taking Morphine sulfate from the FDA, and is updated regularly.

What is Morphine sulfate?

Morphine sulfate has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 87,262 Morphine sulfate users. Check the latest studies of Morphine sulfate.

What is Hepatocellular damage?

Hepatocellular damage (liver damage) is found to be associated with 508 drugs and 610 conditions by eHealthMe. Check the latest studies of Hepatocellular damage.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 20, 2026

86,091 people reported to have side effects when taking Morphine sulfate.
Among them, 28 people (0.03%) have Hepatocellular damage.

Could Morphine sulfate cause Hepatocellular damage?

Among these 28 people:

How long have people been on Morphine sulfate when they have Hepatocellular damage? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Hepatocellular damage when taking Morphine sulfate? *

  • female: 60.71 %
  • male: 39.29 %

What is the age of people who have Hepatocellular damage when taking Morphine sulfate? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 4.55 %
  • 30-39: 4.55 %
  • 40-49: 0.0 %
  • 50-59: 31.82 %
  • 60+: 59.09 %

What are other drugs people take besides Morphine sulfate? *

  1. Bactrim: 6 people, 21.43%
  2. Omeprazole: 5 people, 17.86%
  3. Xanax: 5 people, 17.86%
  4. Acetaminophen: 5 people, 17.86%
  5. Furosemide: 5 people, 17.86%
  6. Lasix: 5 people, 17.86%
  7. Kaletra: 4 people, 14.29%
  8. Efavirenz: 4 people, 14.29%
  9. Abacavir: 4 people, 14.29%
  10. Gemzar: 3 people, 10.71%

What are other side effects people have besides Hepatocellular damage? *

  1. Alanine Aminotransferase Increased: 3 people, 10.71%
  2. Aspartate Aminotransferase Increased: 3 people, 10.71%
  3. Pleural Effusion (water on the lungs): 3 people, 10.71%
  4. Acute Kidney Failure: 2 people, 7.14%
  5. Blood Creatine Phosphokinase Increased: 2 people, 7.14%
  6. Gamma-Glutamyltransferase Increased: 2 people, 7.14%
  7. Hypertriglyceridaemia (excess of triglycerides in the blood): 2 people, 7.14%
  8. Liver Function Tests Nos Abnormal: 2 people, 7.14%
  9. Depressed Level Of Consciousness: 2 people, 7.14%
  10. Dehydration (dryness resulting from the removal of water): 2 people, 7.14%

What are the existing conditions these people have? *

  1. Neuropathic Pain (pain due to nerve inflammation and damage): 1 person, 3.57%
  2. Malignant Melanoma (skin cancer rises from melancytes): 1 person, 3.57%
  3. Guillain-Barre Syndrome (the body's immune system attacks its peripheral nervous system): 1 person, 3.57%
  4. Dyslipidaemia (abnormal amount of lipids): 1 person, 3.57%
  5. Depression: 1 person, 3.57%
  6. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 3.57%
  7. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Morphine sulfate and have Hepatocellular damage?

- Check whether Hepatocellular damage is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Morphine sulfate:

Hepatocellular damage treatments and more:

How severe was Hepatocellular damage and when was it recovered:

Expand to all the drugs that have ingredients of morphine sulfate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Morphine sulfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatocellular damage:

Browse all the conditions that are associated with Hepatocellular damage:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on morphine sulfate (the active ingredients of Morphine sulfate) and Morphine sulfate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.